Applied Microbiology / Biofilms

Bacterial Extracellular Polysaccharides in Biofilm Formation and Function

• Extracellular Polymeric Substances (EPS) Overview:

  • Biofilm construction and architectural stability depend on the production of the extracellular polymeric matrix (EPS).

  • EPS biopolymers are synthesized by diverse microbial strains, providing structural stability, hydrated microenvironments, and nutrient entrapment during sessile microcolony attachment and biofilm development.

  • Chemical Composition of EPS:

    • Water: $96\text{--}97\%$

    • Microbial cells: $2\text{--}5\%$

    • Polysaccharides: $1\text{--}2\%$

    • Proteins (extracellular and lysed): $<1\text{--}2\%$

    • Nucleic acids (eDNA): $<1\text{--}2\%$

    • Ions (bounded and unbounded): Trace quantities

  • Nucleases within the EPS act as critical regulators during biofilm formation and dissolution.

  • Extracellular DNA (eDNA) functions in genetic exchange, intercellular signaling, structural adhesion, and cross-linking within the matrix.

• Architectural Polysaccharides in Biofilms:

  • Bacterial Alginates:

    • High-molecular-weight linear copolymer consisting of $\beta\text{-D-mannuronate}$ (M component) and $\text{C5}$ epimer $\text{-}\text{-L-guluronate}$ (G component) residues joined via 1,4-glycosidic linkages.

    • Predominantly produced by Pseudomonas aeruginosa and Azotobacter vinelandii.

    • Controlled by the 24-gene chromosome cluster in P. aeruginosa, including the 8-gene exportation cassette and 4-gene synthesis complex. Biosynthesis operon ($algD\text{-}A$) is governed by the alternative sigma factor $AlgT$ ($AlgU/\text{-}^{E}/\text{-}^{22}/RpoE$), which is antagonized by the anti-sigma factor $MucA$. Additional regulators include $AlgR$, $IHF$, $AlgB$, $AmrZ$, $MucB\text{--}E$, $MucP$, $AlgW$, $KinB$, and $ClpX$ proteases.

    • High hygroscopic property provides protection against desiccation and promotes fluid transport within CF (cystic fibrosis) pulmonary infections.

*   **Cellulose**:
    *   Linear homopolymer of $\beta\text{-1,4-linked}$ D-glucose chains aligned via inter- and intra-chain hydrogen bonds to form highly crystalline fibrils.
    *   Synthesized in *Salmonella typhimurium*, *Escherichia coli*, *Acetobacter*, *Rhizobium*, and *Agrobacterium* by the bacterial cellulose synthesis operon ($bcsA$, $bcsB$, $bcsZ$, and $bcsC$), regulated by the master transcriptional activator $AgfD$.
    *   Exhibits gelation behavior at temperatures higher than $50\,^\circ\text{C}$ or lower than $10\,^\circ\text{C}$.

*   **Poly-N-Acetylglucosamine (PNAG) / Polysaccharide Intercellular Adhesin (PIA)**:
    *   Positively charged linear homoglycan composed of $\beta\text{-1,6-N-acetylglucosamine}$ residues ($20\%$ deacetylated).
    *   Encoded by the $icaADBC$ operon and regulated negatively by the $icaR$ gene in *Staphylococcus aureus* and *Staphylococcus epidermidis*.
*   **Capsular Polysaccharides (CPS)**:
    *   Covalently linked to cell-surface phospholipids or Lipid-A moieties; hydrates the biofilm and protects cells from opsonophagocytosis, complement killing, and cationic antimicrobial peptides.
    *   Encompasses $80$ K-antigen CPS types in *E. coli* and $93$ distinct serotypes in *Streptococcus pneumoniae*.
*   **Levan**:
    *   High-molecular-weight neutral homopolymer of $\beta\text{-D-fructans}$ synthesized from extracellular sucrose by secreted levansucrase ($sacB$ and $sacC$ genes in *Bacillus subtilis*).
    *   Regulated by two-component systems ($GacS/GacR$, $EnvZ/OmpR$, $CovS/CovR$, $SacX/SacY$).
*   **Colanic Acid (CA / M Antigen)**:
    *   Complex branched polysaccharide containing glucose, galactose, fucose, and glucuronic acid.
    *   Synthesized by the 19-gene $wca$ cluster ($cps$ locus) in Enterobacteriaceae via the $Rcs$ phosphorelay system ($RcsC \rightarrow RcsD \rightarrow RcsB$ with $RcsA$ accessory protein).
*   **Vibrio Polysaccharide (VPS)**:
    *   Essential for *Vibrio cholerae* rugose colony morphology and chlorine resistance.
    *   Composed of glucose ($52.6\%$), galactose ($37.0\%$), N-acetylglucosamine ($5.1\%$), mannose ($3.8\%$), and xylose ($1.5\%$).
    *   Encoded by two operons ($vpsA\text{--}K$ and $vpsL\text{--}Q$), transcriptionally activated by $VpsR$ and $VpsT$ (bound to $c\text{-di-GMP}$) and repressed by $HapR$.

• Methods of Exopolysaccharide Extraction:

  • Physical Extraction Methods: Application of shear forces via centrifugation ($10,000 \times g$ for $30\,\text{min}$ or $40,000 \times g$ for $2\,\text{h}$ at $10\,^\circ\text{C}$), high-speed mixing, ultrasonication, heat treatment, and dialysis.

  • Chemical Extraction Methods: Chelation of divalent cations using EDTA ($15\%$ concentration at $5\,^\circ\text{C}$ for $3\,\text{h}$), cation exchange resins (Dowex), $\text{NaOH}$, and formaldehyde precipitation.

• Functional Attributes of Microbial EPS:

  • Adhesion & Cohesion: Mediates primary surface attachment and cell-to-cell structural integrity via Van der Waals, electrostatic, and hydrogen-bonding interactions.

  • Symbiosis: Succinoglycan production by Sinorhizobium meliloti Rm1021 interacts with host receptor EPR3 in Lotus japonicus to initiate legume root nodulation.

  • Pathogenicity & Defense: Protection against reactive oxygen species ($\text{H}_2\text{O}_2$) via antioxidant buffering; barriers against phagocytosis and antibody binding.

  • Antimicrobial Recalcitrance: EPS acts as a diffusion barrier preventing antibiotic penetration and neutralizing charges on antimicrobial molecules.

Pseudomonas putida Biofilm: Development and Dynamics

• Overview of Pseudomonas putida:

  • Ubiquitous Gram-negative soil and rhizosphere saprophytic bacterium (P. putida KT2440), certified as a Generally Recognized As Safe (GRAS) host-vector system.

  • Metabolic versatility enables production of medium-chain-length polyhydroxyalkanoates (mcl-PHA), $5\text{-methyl-phenazine-1-carboxylic acid}$, pyoverdine, $p\text{-coumarate}$, $pretubulysin A$, and lipopeptide biosurfactants ($putisolvins$ I and II).

• Molecular Dynamics of P. putida Biofilm Formation:

  • Intracellular Signaling: Controlled by cyclic diguanylate ($c\text{-di-GMP}$) homeostasis through diguanylate cyclases (GGDEF domain) and phosphodiesterases (EAL or HD-GYP domains).

  • LapA-LapD-LapG System:

    • Large adhesin protein A ($LapA$) executes irreversible surface attachment.

    • Periplasmic protease $LapG$ cleaves $LapA$ from the cell surface when $c\text{-di-GMP}$ levels are low.

    • Transmembrane receptor $LapD$ binds $c\text{-di-GMP}$ at high intracellular levels, sequestering $LapG$ and maintaining cell-surface $LapA$ expression.

    • $BifA$ phosphodiesterase degrades $c\text{-di-GMP}$ during carbon/nutrient starvation, triggering $LapG$ activation and biofilm dispersal.

• Factors Influencing P. putida Biofilms:

  • Temperature Stress: Thermotolerant strain NBRI0987 forms robust biofilms at $40\,^\circ\text{C}$ in the presence of $\text{MgSO}_4$ and glycerol, regulated by stress sigma factor $RpoS$ ($\sigma^S$).

  • Flagella and Motility: Regulated by transcriptional regulator $FleQ$ and export machinery ($fliP$, $flgG$, $flhF$). Non-flagellated $fliM$ mutants still construct structured biofilms, whereas $morA$ mutants display hyper-flagellation but fail to attach.

  • Regulatory Circuitry: Operon containing $PP0164$ and $PP0165$ regulates matrix development. Tol-Pal system ($tolQ$, $tolR$, $tolA$, $tolB$, $pal$, $oprL$) maintains outer membrane integrity. RNA-binding proteins ($RsmA$, $RsmE$, $RsmI$) repress the GGDEF/EAL protein $CfcR$.

• Biofilm Control Strategies:

  • Physical Methods: High-intensity light pulses, X-ray irradiation, UV-C treatment, ultrasound with ozonation, electrolyzed water, and pipe pigging.

  • Chemical Agents: Aggressive disinfectants ($\text{NaOCl}$, glutaraldehyde, peracetic acid, $\text{H}_2\text{O}_2$), Quaternary Ammonium Compounds (QACs/QCCs like benzalkonium chloride), biosurfactants (rhamnolipids), Cationic Antimicrobial Peptides (CAPs / AMPs like bovine lactoferrin-derived peptides BLFP), Quorum Sensing Inhibitors (cinnamaldehyde, nitric oxide).

  • Nanoparticles: Graphene oxide (GO-120 at $85\,\mu\text{g/mL}$) achieves extensive dispersal of $48\,\text{h}$ mature biofilms; Zinc oxide (ZnO) at Concentrations $> 30\,\text{mg/L}$ inhibits biofilm development.

*   *Biological Control*: Podoviridae phage AF ($42.6\,\text{kb}$ genome) and T7-like phage $\phi 15$ encode virion-associated exopolysaccharide depolymerases ($Gp19$ tail spike) that degrade EPS matrices.

Biofilm Matrix Proteins

• Structural and Functional Roles of Matrix Proteins:

  • Matrix proteins mediate cell-to-surface adhesion, intercellular aggregation, enzymatic matrix degradation, and structural stabilization across environmental gradients.

  • Matrix components represent up to $90\%$ of the total dry mass of mature biofilms.

• Key Biofilm Matrix Proteins:

  • Accumulation-Associated Protein (Aap):

    • $220\,\text{kDa}$ surface protein in Staphylococcus epidermidis (ortholog $SasG$ in S. aureus).

    • Composed of an N-terminal A domain (16-amino acid repeats) and a C-terminal B domain ($3\text{--}17$ repeating units) containing a $G5$ domain.

    • Proteolytic cleavage of the A domain exposes the B domain $G5$ repeats to drive zinc-dependent intercellular aggregation.

*   **Rugosity and Biofilm Structure Modulator A (RbmA)**:
    *   $26\,\text{kDa}$ protein secreted by *Vibrio cholerae*.
    *   Contains two tandem fibronectin type III (FnIII) domains folding into seven-strand $\beta\text{-sandwiches}$ with a positively charged arginine groove that binds cell-surface polysaccharides.

*   **Biofilm-Associated Protein (Bap)**:
    *   $239\,\text{kDa}$ cell-surface protein in *S. aureus*.
    *   Contains an N-terminal signal sequence, A region, B domain, C core domain (13 identical tandem repeats forming $\beta\text{-sandwiches}$), D region, and a C-terminal LPxTG cell-wall anchoring motif.

*   **Biofilm-Surface Layer Protein (BslA)**:
    *   $19.11\,\text{kDa}$ surface-active protein produced by *Bacillus subtilis*.
    *   Features an immunoglobulin-like fold and a surface-exposed hydrophobic "cap" that forms an armor-like hydrophobic coat over the biofilm surface, rendering it highly water-repellent.

*   **GlcNAc-Binding Protein A (GbpA)**:
    *   $53.62\,\text{kDa}$ chitin-binding protein in *V. cholerae* secreted via the Type II secretion system.
    *   Organized into four domains ($D1\text{--}D4$); terminal domains $D1$ and $D4$ bind chitin/zooplankton surfaces, while $D2$ and $D3$ anchor to the bacterial cell surface.

• Extraction Methods for Matrix Proteins:

  • Chemical extraction using $1.5\,\text{M}\ \text{NaCl}$, sodium dodecyl sulfate (SDS), or lithium chloride ($\text{LiCl}$).

  • Enzymatic isolation employing Proteinase K digestion.

Microbial Biofilm: Bioremediation and Wastewater Treatment

• Foundational Principles & Impact:

  • Biofilms represent surface-attached syntrophic communities of microbial cells embedded within a self-produced EPS matrix.

  • Historical milestones: Antonie van Leeuwenhoek (1674/1684), Heukelekian and Heller (1940 - "bottle effect"), Zobell (1943), Costerton et al. (1978/1999).

• Stages of Biofilm Formation:

  1. Preconditioning & Reversible Attachment: Conditioning film formation; weak Van der Waals and electrostatic interaction.

  2. Irreversible Attachment: Production of exopolysaccharides, pili, type IV fimbriae, and cell-surface adhesins forming organic bridges.

  3. Microcolony Formation: Binary fission and cell cluster recruitment.

  4. Biofilm Maturation: Development of 3D pillar/mushroom architectures interspaced with fluid-filled nutrient channels.

  5. Detachment / Dispersal: Enzymatic cleavage of matrix (lyases, depolymerases) and physical shear stress (sloughing, shearing, and abrasion).

• Biofilm-Based Wastewater Treatment Technologies:

  • Trickling Filters (TF): Packed bed media (rocks, plastic); achieves $60\%\text{--}85\%$ BOD removal at $1\,\text{kg BOD/m}^3/\text{day}$.

  • Rotating Biological Contactors (RBC): Rotating plastic discs ($190\,\mu\text{m}$ biofilm thickness); eliminates $79.2\%\text{--}83.4\%$ nitrate-nitrogen and $91.6\%\text{--}94.4\%$ phosphate-phosphorus.

  • Constructed Wetlands (CWs): Subsurface horizontal/vertical flow systems achieving $50\%$ BOD, $44\%$ COD, $78\%$ TSS, and $98\%$ fecal coliform removal.

  • Membrane Biofilm Reactors (MBR / BF-MBR): Immersed or external side-stream filtration configuration; operating loads of $6\text{--}96\,\text{g COD/m}^2/\text{d}$, achieving up to $95.1\%$ COD removal and total perchlorate ($\text{ClO}_4^-$) degradation to $< 4\,\mu\text{g/L}$.

  • Fluidized-Bed Biofilm Reactors (FBBR): Small fluidized carrier particles ($< 1\,\text{mm}$) with high biomass concentration ($30,000\text{--}40,000\,\text{mg/L}$ volatile solids); removes $99\%$ nitrates within $6\,\text{min}$ hydraulic retention time (HRT).

Bacillus subtilis-Based Biofilms

• Model Characteristics of B. subtilis:

  • Gram-positive motile endospore-forming rod. Model wild strain B. subtilis NCIB3610 produces structured, wrinkled colonies and robust air-liquid interface pellicles, whereas laboratory strain 168 derivatives lack robust macrostructures.

• Regulatory Architecture of B. subtilis Biofilm Development:

  • Global Regulators: Master transcriptional repressor $SinR$ represses matrix production genes ($epsA\text{-}O$ and $tasA\text{-}ypqA\text{-}yqxM$ operons) in planktonic cells.

  • Anti-repressors: $SinI$, $YlbF$, and $YmcA$ directly or indirectly antagonize $SinR$.

  • Master Switch: $Spo0A$ phosphorylation activates $SinI$ expression under starvation/high cell density.

  • Matrix Components: EPS (produced by 16-gene $epsA\text{-}O$ operon) and functional amyloid fibers of $TasA$ protein (anchored by $YqxM/TasA$ complex).

• Engineered B. subtilis Biofilm Applications:

  • Functionalized living materials, self-healing biocatalytic membranes, biocompatible tissue-bonding adhesive hydrogels, and anti-corrosive coatings for steel protection.

Contamination Caused by Bacterial Biofilms and Remediation

• Stages of Contamination & Biofilm Development:

  • Stage 1: Reversible attachment of free-swimming cells.

  • Stage 2: Irreversible attachment, chemical signal secretion, activation of EPS synthesis.

  • Stage 3: Maturation I ($> 10\,\mu\text{m}$ thick cell aggregates).

  • Stage 4: Maturation II ($> 100\,\mu\text{m}$ 3D mushroom/pillar structures).

  • Stage 5: Dispersal via saccharolytic enzymes (e.g., alginate lyase).

• Quorum Sensing Classification:

  • LuxI/LuxR Type: Gram-negative bacteria; utilizes N-acyl-homoserine lactones (AHL).

  • Oligopeptide-Two Component Type: Gram-positive bacteria; utilizes modified signal peptides.

  • LuxS Type: Gram-positive and Gram-negative bacteria; utilizes Autoinducer-2 (AI-2).

• Medical & Industrial Biofilm Infections:

  • Dental Plaque & Periodontitis: Over $10^{11}$ microorganisms per mg plaque (Streptococcus mutans, Actinomyces, Porphyromonas gingivalis, Treponema denticola).

  • Urinary Catheters: Urease-producing Proteus mirabilis degrades urea to ammonia, raising pH and precipitating crystalline struvite ($\text{MgNH}_4\text{PO}_4\cdot 6\text{H}_2\text{O}$) and hydroxyapatite ($\text{Ca}_{10}(\text{PO}_4)_6(\text{OH})_2$) encrustations.

  • Central Venous Catheters (CVC): Short-term ($< 10$  days, external surface) vs. long-term ($> 30$  days, internal lumen) colonization by S. epidermidis, S. aureus, P. aeruginosa, and Enterobacter.

• Biofilm Remediation Strategies:

  • Sortase Inhibition: Targeting Sortase A ($srtA$) membrane transpeptidases to prevent covalent cleavage and LPxTG-anchoring of surface adhesins.

  • Nanotechnology: Tellurium nanoparticles (TeNPs) cause $90\%$ biovolume reduction; Silver nanoparticles (AgNPs) and amphiphilic block copolymer nanoparticles (DA95B5) execute nanoscale bacterial debridement.

  • Superparamagnetic Iron Oxide Nanocarriers (SPIONs / IOPs): Oleic acid-capped iron oxide cores encapsulated in polymeric shells for magnetic-targeted biofilm penetration.

  • Synthetic Inhibitors:

    • Imidazole derivatives: 2-aminoimidazole triazoles, 2-aminobenzimidazoles.

    • Indole derivatives: 7-hydroxyindole, 5-hydroxyindole, 3-indolylacetonitrile (IAN), indole-3-carboxyaldehyde (I3CA).

    • Plant compounds: Emodin, flavonoids, ginger extracts, Hypericum perforatum extracts.

    • Marine compounds: Auromomycin, furanones, 4-thiazolidinone bromopyrrole, Skyllamycin B.

Pseudomonas putida Biofilms: Stress, Physiology, and Properties

• Water Stress Physiology:

  • Water potential ($\psi$) comprises solute potential and matric potential. Decreased matric potential induces severe desiccation stress in terrestrial soil and rhizosphere environments.

  • P. putida produces exopolysaccharides (pea, peb, alg, bcs) to maintain hydration under low matric potential.

• Extracellular Matrix & Adhesins:

  • pea (putida exopolysaccharide A): Encodes glucose- and mannose-rich polymer required for pellicle and biofilm structural stability.

  • bcs (bacterial cellulose): Induced under desiccation and osmotic stress.

  • alg (alginate): Induced in response to copper stress and severe desiccation in alginate-deficient compensation pathways.

  • Adhesins $LapA$ and $LapF$ stabilize cell-surface and cell-to-cell associations.

• Quorum Sensing & Antibiotic Resistance:

  • PpuI/PpuR system utilizes $3\text{-oxo-C12-HSL}$, $3\text{-oxo-C10-HSL}$, $3\text{-oxo-C8-HSL}$, and $3\text{-oxo-C6-HSL}$.

  • Sub-inhibitory concentrations of tetracycline, hydroxytetracycline, fluoroquinolones, rifampicin, and imipenem upregulate $LapA$ expression, promoting hyper-biofilm formation and conferring multidrug tolerance.

Mechanisms of Competition in Biofilm Communities

• Modes of Ecological Competition:

  • Exploitative (Scramble) Competition:

    • Indirect competition via depletion of shared limiting resources (carbon, oxygen, nitrogen, and essential metal ions like iron).

    • Siderophore scavenging: Secretion of iron-chelating molecules (pyoverdine, enterobactin); exploited by non-producing "cheater" subpopulations.

  • Interference (Contest) Competition:

    • Direct biological or chemical antagonism to harm or exclude competitors.

    • Bacteriocins and toxins: Microcins, colicins (coded by plasmid-borne $kil$ genes), pyocins (Pseudomonas), pesticins (Yersinia pestis), and klebicins (Klebsiella).

    • Competition sensing & Quorum sensing: Detection of cell damage or nutrient stress triggers targeted counter-attacks; Quorum Quenching enzymes degrade rival autoinducers (AHL lactonases).

    • Dispersal factors: Production of $cis\text{-2-decenoic acid}$ and nitric oxide (NO), activating phosphodiesterases to degrade $c\text{-di-GMP}$ and induce biofilm dissolution.

    • Fruiting bodies: Starvation-induced multicellular spore-bearing bodies in Myxococcus xanthus and Dictyostelium discoideum.

    • Contact-Dependent Inhibition (CDI): CdiB/CdiA two-partner secretion system delivers toxic C-terminal domain ($CdiA\text{-CT}$) into target cells; producer cells express $CdiI$ immunity protein.

    *   Outer Membrane Exchange (OME): Mediated by $TraAB$ receptor complexes in *Myxococcus*.
    *   Type VI Secretion System (T6SS): Contractile molecular syringe delivering bactericidal effector toxins directly into target cell periplasm or cytoplasm.

• Analytical Techniques for Biofilm Competition Studies:

*   Microfluidics ("lab-on-a-chip" BIOFLUX systems).
*   Microscopic Imaging: Environmental SEM (ESEM), Variable Pressure SEM (VPSEM), Field Emission SEM (FESEM), CRYO-SEM, Atmospheric SEM (ASEM).
*   Proteomics & Metabolomics: 2D-DIGE, LC-MS, NanoDrop spectrophotometry.
*   Genomics & Transcriptomics: DNA microarrays, RNA-seq, Single-cell genomics, Metagenomics.

Escherichia coli Biofilms: Adhesion, Matrix, and Regulation

• Overview of E. coli Biofilm Lifecycle:

• Adhesion Systems in E. coli:

  • Flagella: Peritrichous flagella drive initial surface contact, swimming motility, and overcome hydrodynamic repulsion. Rotational speed regulated by $c\text{-di-GMP}$ via the $YcgR$ flagellar brake.

  • Type 1 Fimbriae: Chaperone-usher pathway pili encoded by the $fim$ operon. $FimH$ adhesin at the tip binds terminally located $\text{D-mannose}$ moieties on host cell glycoproteins.

  • Curli Fimbriae: Amyloid fibers encoded by $csgBA$ (structural subunits $CsgA$/$CsgB$) and $csgDEFG$ (master transcriptional regulator $CsgD$ and export complex $CsgE\text{-}G$) operons. Bind fibronectin, laminin, and plasminogen.

  • Conjugative Pili (F-pili): Encoded by F-plasmid; facilitates physical cell-to-cell contact, stabilization of matrix, and horizontal transfer of resistance plasmids.

  • Autotransporters: Antigen 43 ($Ag43$, encoded by $flu$ gene) contains a $\beta\text{-barrel}$ transporter and $\alpha\text{-passenger}$ domain; drives self-recognition and autoaggregation. Additional autotransporters include $AidA$ and $TibA$.

• Matrix Components:

  • Poly-$\beta$-1,6-N-Acetylglucosamine (PGA): Encoded by $pgaABCD$ operon; exported by outer membrane proteins $PgaA$ and $PgaB$.

  • Colanic Acid (CA): Encoded by 19-gene $wca$ cluster, regulated by $RcsCDB$ system.

  • Cellulose: Encoded by $bcsABZC$ and $bcsEFG$ operons, activated allosterically by $c\text{-di-GMP}$.

  • eDNA: Released via cell lysis or vesicles; maintains structural integrity and facilitates gene exchange.

• Regulatory Networks:

  • Phase Variation: Reversible inversion of the $fimS$ promoter element by recombinases $FimB$ and $FimE$. $Ag43$ phase variation regulated by $OxyR$ repressor and DNA adenine methylase ($Dam$).

  • Two-Component Systems:

    • $CpxAR$: Senses envelope stress via outer membrane lipoprotein $NlpE$; $CpxR\text{-}P$ regulates surface attachment and represses curli/F-pili under severe stress.

    • $RcsCDB$: Senses membrane perturbation and desiccation; $RcsB\text{-}P$ activates colanic acid synthesis ($wca$) and represses flagellar motility.

    • $EnvZ/OmpR$: Senses osmolarity changes; $OmpR\text{-}P$ activates $CsgD$ (curli/cellulose) and regulates porins $OmpF$ and $OmpC$.

  • Small Molecules: $c\text{-di-GMP}$ (synthesized by 19 GGDEF domain proteins), Alarmone $\text{ppGpp}$ (stringent response synthesized by $relA$ and $spoT$), $N\text{-Acetylglucosamine-6-P}$.

  • Carbon Flux Regulation: $CRP\text{-cAMP}$ complex, $CsrA$ protein (represses glycogen synthesis and PGA, regulates $flhDC$), antagonized by small non-coding RNAs $CsrB$ and $CsrC$.

Microbial Biofilms in Bioremediation of Organic Pollutants in Aquatic Bodies

• Aquatic Pollution & Ecotoxicology:

  • Industrial effluents, paper mill processing wastes, pharmaceutical personal care products (PPCPs), and agricultural runoffs contribute heavy metal, dye, and pesticide pollution.

  • Antibacterials (oxytetracycline - $90\%$ excreted unabsorbed; chloramphenicol, flumequine, oxolinic acid, furazolidone), parasiticides (organophosphates like Nuvan and Neguvon toxic to lobsters at $0.1\text{--}0.5\,\text{ppm}$), and pesticides (carbaryl / Sevin applied at $11.3\,\text{kg/ha}$ toxic to Dungeness crab at $0.1\,\text{ppm}$).

• Bioaugmentation Mechanisms:

  • Assimilation: Uptake of nitrogen and phosphorus during aerobic/anaerobic sludge cycling.

  • Biosorption: Surface binding of heavy metals and recalcitrant compounds by EPS functional groups (carboxyl, hydroxyl, sulfhydryl, phenolic, phosphoric).

  • Biodegradation: Enzymatic oxidation of xenobiotics and aromatic hydrocarbons using laccases and manganese peroxidases (MnP).

Bacterial Extracellular Polymeric Substances in Biofilm Matrix

• Composition & Macromolecular Features:

  • EPS constitutes $50\%\text{--}90\%$ of total organic matter in microbial biofilms, with macromolecular masses ranging from $0.5 \times 10^6$ to $2.0 \times 10^6\,\text{Da}$.

• Model Bacterial EPS Systems:

  • Bacillus subtilis: 15-gene $epsA\text{-}O$ operon and $yhxB$ gene; produces poly-$\gamma\text{-glutamate}$ ($\gamma\text{-PGA}$).

  • Staphylococcus aureus: PIA / PNAG synthesized by $icaADBC$ operon.

  • Pseudomonas aeruginosa: Pel (glucose-rich) and Psl (mannose- and galactose-rich, encoded by $pslACDEFGHIJKL$).

  • Vibrio cholerae: VPS (encoded by $vpsA\text{--}K$ and $vpsL\text{--}Q$).

Algal Biofilms: Wastewater Treatment Applications and Biotechnological Significance

• Composition & Ecosystem Dynamics:

  • Composed of photoautotrophic microalgae (diatoms/Bacillariophyceae like Amphora coffeaeformis, Cylindrotheca closterium, Nitzschia, Navicula; Chlorophyceae like Chlorella, Scenedesmus, Enteromorpha; Cyanophyceae like Oscillatoria, Chroococcus, Lyngbya) and heterotrophic bacteria.

• Cultivation & Growth Conditions:

  • Light Energy: Photosynthetically active radiation (PAR) optimal at $100\text{--}600\,\mu\text{mol/m}^2/\text{s}$; photoinhibition occurs at high light intensities.

  • Systems: Open raceway ponds ($0.25\text{--}1\,\text{g/L}$ density), Photobioreactors (PBR; $1.5\text{--}1.7\,\text{g/L}$ density), Revolving Algal Biofilm Reactors (RABR; up to $70\,\text{g/L}$ density), Algal Turf Scrubbers (ATS; yields $> 20\,\text{g/m}^2/\text{d}$).

  • Carbon Capture: Fixes anthropogenic $\text{CO}_2$ into high-density lipid and carbohydrate biomass.

Antimicrobial Tolerance in Biofilms

• Fundamental Concepts:

  • Antimicrobials vs. Antibiotics: Antimicrobials include natural, synthetic, or semi-synthetic agents against all microbes; antibiotics are microbial-derived substances targeting bacteria.

  • Classification: Range of action, cidal vs. static impact, mode of action (cell wall synthesis, cell membrane integrity, protein synthesis, nucleic acid synthesis, metabolic pathways).

• Biocide Chemistries:

  • Halogens: Chlorine and bromine compounds hydrolyze to hypochlorous acid ($\text{HOCl}$) and hypobromous acid ($\text{HOBr}$); halogenated hydantoins (DMH, MEH).

  • Phenolics: Phenol (carbolic acid), 2-phenylphenol, thymol, carvacrol, eugenol.

  • Quaternary Ammonium Compounds (QACs): Cationic surfactants ($\text{NR}_4^+ X^-$) disrupting cell membranes (benzalkonium chloride, cetylpyridinium chloride).

  • Aldehydes: Glutaraldehyde, formaldehyde (formalin $34\%\text{--}40\%$).

  • Essential Oils: Volatile plant extracts containing terpenoids, phenylpropanoids.

  • Peroxides: Hydrogen peroxide ($\text{H}_2\text{O}_2$ at $3\%\text{--}6\%$), peracetic acid; generates damaging hydroxyl radicals ($\text{OH}^\bullet$).

Biofilm-Based Antimicrobial Tolerance and Resistance

• Tolerance vs. Resistance Parameters:

  • Antimicrobial Resistance: Ability to grow at elevated drug concentrations; measured by Minimum Inhibitory Concentration (MIC).

  • Antimicrobial Tolerance: Ability of a bacterial population to survive lethal antibiotic concentrations without increasing MIC; measured by Minimum Duration of Killing ($\text{MDK}_{99}$).

• Mechanisms of Recalcitrance:

  1. Persister Cells: Non-growing, dormant phenotypic variants formed via toxin-antitoxin modules (e.g., $hipA$ gene mutation).

  2. Diffusion Barrier: Matrix EPS delays or prevents antibiotic penetration.

  3. Physiological Heterogeneity: Micro-gradients of oxygen, pH, and nutrients create localized metabolically inactive zones.

  4. Toxin-Antitoxin (TA) Modules: Types I–VI; $MqsR$ toxin induces oxidative stress and persistence.

  5. Multidrug Efflux Pumps: RND superfamily ($AcrAB\text{-}TolC$ system) actively extrudes toxic molecules.

  6. Quorum Sensing & Stress Responses: Signaling molecules trigger localized adaptive responses; stringent response ($\text{ppGpp}$ synthesized by $relA$ and $spoT$) arrests growth under starvation.

• Strategies to Combat Biofilm Recalcitrance:

  • Essential Oils & Phenolics (carvacrol, thymol, eugenol).

  • Bacteriophage Therapy: Lytic phages expressing endolysins and depolymerases.

  • Electrochemical Scaffolds: Low-level $\text{H}_2\text{O}_2\text{-generating}$ e-scaffolds.

  • Quorum Sensing Inhibitors (QSIs): RNA-III-inhibiting peptide (RIP), usnic acid, 6-gingerol, flavonoids.

  • Combination Antibiotic Therapy: Colistin coupled with meropenem, tobramycin, or ciprofloxacin.

  • Antimicrobial Peptides (AMPs): Synthetic peptide 1018, nisin, indolicidin.

  • Quaternary Ammonium Compounds: Novel tetracationic/tris-QACs (XF-70, XF-73).

  • Biosurfactants: Rhamnolipids and Lactobacillus-derived biosurfactants.